Delivery Order SPE2DB24D1021-SPE2DB25FFAAZ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine 1,000 mg suppositories (30-count units) valued at $2,493.62, with an ultimate completion date of August 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and falls under a delivery order contract type. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Mesalamine 1,000 mg suppositories in a 30-count package. This non-competitive, firm fixed-price delivery order has a ceiling value of $2,509.47 and an ultimate completion date of August 26, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,133.89, is for the delivery of Mesalamine 1,000 mg suppositories. It is a Firm Fixed Price Delivery Order contract with a completion date of March 19, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,286.99 to AmerisourceBergen Drug Corp for 120 tablets of Mesalamine DR 1.2 GM on August 15, 2025, with completion targeted for August 18, 2025. This firm fixed price delivery order represents a non-set-aside award issued under competitive procurement procedures. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count) with a ceiling value of $1,512.73. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a $1,694.97 delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count unit) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- This federal contract award is for the delivery of Mesalamine 1,000 mg suppositories to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,968.88 and an ultimate completion date of March 28, 2025. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 27, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,044.12, is a delivery order issued by the Defense Logistics Agency (DLA) for the procurement of 4,567,342,783 units of Mesalamine 1,000 mg suppositories. The contract has an ultimate completion date of February 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $303.28 to Amerisourcebergen Drug Corporation for the supply of 1,000 units of 1,000 mg mesalamine suppositories. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 23, 2023 under the terms of the order. The parent company, Amerisourcebergen Corporation, will perform through its Amerisourcebergen Corporation...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count units) under a firm fixed-price contract valued at $3,199.95. The award was issued on August 22, 2025, with an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFAAZDelivery Order
The Defense Logistics Agency awarded a $1,239.90 delivery order to AmerisourceBergen Drug Corp for 30 units of Mesalamine 1,000 mg suppositories under a firm fixed-price contract. The delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a competitively awarded, non-set-aside procurement executed through the company's existing contract vehicle with DLA. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, a $999.99 billion comprehensive global pharmaceutical support vehicle valued through December 2026. As the prime contractor on this IDC, AmerisourceBergen supplies a broad range of pharmaceutical products and medical supplies to support military and federal healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. The delivery order exemplifies the company's role as a critical pharmaceutical distributor fulfilling diverse medical supply requirements for federal healthcare programs through flexible, competitively awarded contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/27/25 |